A phase Ib trial of omadacycline in patients with uncomplicated urinary tract infection
Phase of Trial: Phase I
Latest Information Update: 24 May 2017
At a glance
- Drugs Omadacycline (Primary) ; Omadacycline (Primary)
- Indications Bacterial infections; Urinary tract infections
- Focus Proof of concept; Therapeutic Use
- 24 May 2017 Data from this trial will be presented at the ASM Microbe 2017, according to a Paratek Pharmaceuticals media release.
- 03 Apr 2017 According to a Paratek Pharmaceuticals media release, positive top-line PK proof-of-principle data was reported in November 2016.
- 02 Nov 2016 Status changed from recruiting to completed., according to a Paratek Pharmaceuticals media release.